Search

everythinglearnresearchcommunity

for

Search:↓

New findings suggest targeting IL-23 could treat psoriasis, skin cells can adapt to new roles, direct conversion of skin cells to blood cells may aid cell therapy, removing certain tumor cells could boost cancer immunotherapy, and melanoma may have many tumorigenic cells, not just cancer stem cells.

Blocking CD44 can reduce leukocyte migration in autoimmune skin diseases.

Hair follicle cells help protect against immune attacks by regulating T-cell activity.

Certain NK cell changes in blood may indicate alopecia areata progression.

Alopecia areata patients have more activated T cells in their blood, which may help in developing treatments.

Lgr5+ stem cells do not cause skin tumors.

Certain human skin cells marked by CD44 and ALDH are rich in stem cells capable of long-term skin renewal.

CD80CD86 deficiency causes hair loss by disrupting regulatory T cells.

Different markers are found in stem cells of the scalp's hair follicle bulge and the surrounding skin.

Alopecia areata involves unique activation of certain immune cells.

NKG2D+CD4+ T cells are higher in alopecia areata patients and may be involved in the disease.

A specific genetic trait in tumor cells is linked to longer survival without disease in certain lymphoma patients.

Mouse skin cancer progression involves a unique group of cells marked by ABCG2 and MTS24.

Certain immune markers may predict chemotherapy response in mesothelioma, and nivolumab is a tolerable and effective treatment for advanced non-small cell lung cancer.

Scientists found a new type of skin cell that could help with skin repair and these cells work better with a certain protein.

Mouse skin has special cells in the epidermis that decrease with age and are linked to keratinocyte stem cells.

Increasing PDCD4 protein may help prevent or treat some skin cancers.

Thymic transplantation normalized some T-cells but not others, maintaining immune function.

Basal cell carcinomas may use IDO to protect themselves from the immune system.

Alopecia areata patients have fewer protective regulatory B cells, which may contribute to the disease.

Hair follicles help skin immune recovery after UVB exposure.

The new ddPCR method reliably detects unwanted viruses in CAR-T cell products, ensuring their safety for patients.

CD133+ cells are crucial for hair growth.

In alopecia areata, certain immune cells increase and express a protein linked to immune activation.

Patients with severe active alopecia areata have lower CD200 expression and an imbalance in their immune system.

Patients with Alopecia areata have fewer specific immune cells that normally regulate the immune system, which may contribute to the condition.

Lower proximal cup cells, not bulge stem cells, regenerate hair follicles after chemotherapy.

Nestin helps identify certain melanoma cells in nodular melanoma.

Increased TEMRA cells can predict treatment outcomes in rapidly progressive alopecia areata.